BackNuestros servicios

Nuestra reputación como líderes en finanzas corporativas se basa en nuestro conocimiento, enfoque sectorial y oferta de servicios a medida.

BackNuestros sectores

Nuestra cultura se basa en ayudar a los clientes a alcanzar sus objetivos a través de nuestro amplio conocimiento del sector.

Clearwater International advises the management team at Rosemont Pharmaceuticals on its MBO with Inflexion

Clearwater International has advised the management team at Rosemont Pharmaceuticals (Rosemont), the UK’s leading liquid pharmaceuticals business, on its carve out from US listed company Perrigo, to Inflexion.

Rosemont’s portfolio of over 130 oral liquid medicines includes over 70 licensed products which are sold into the UK as well as the US, Continental Europe and the Middle East. The business benefits from strong R&D and innovation, and has built a track record of successful new product launches.

With substantial experience in successfully executing carve-outs, Inflexion will draw upon its healthcare expertise to establish Rosemont as a standalone business and invest further in innovation and new product development. Inflexion will also support the geographical expansion of the business.

    Image of Inflexion Company Logo
    adquirió
    Image of Rosemont Pharmaceuticals Company Logo
    por parte de
    Image of Perrigo Company Logo
    Asesoramiento de gestión
    No divulgado
    View Back of Transaction
    Asesores de Clearwater

    Adviser to the management team of Rosemont Pharmaceuticals in respect of its acquisition by Inflexion from Perrigo

    Ver más

Asesores de Clearwater

Volver a transacciones
Scroll to Top